{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:52:48Z","timestamp":1793289168355,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Remimazolam tosilate (HR7056, RT), a novel ultrashort-acting benzodiazepine, can be used for procedural sedation and general anaesthesia. However, few studies have focused on the sedative effect of RT during gastrointestinal endoscopy in elderly patients. The purpose of this study is to compare the sedative effect of RT and propofol for gastrointestinal endoscopy in elderly patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 82 patients aged \u226565\u2009years with an American Society of Anaesthesiologists (ASA) grade I-II and a body mass index (BMI) of 18.0 to 30.0\u2009kg\/m<jats:sup>2<\/jats:sup> who were scheduled for gastrointestinal endoscopy from Jan 2021 to Aug 2021 were selected and randomly divided into a RT group and a propofol group. Alfentanil 5\u2009\u03bcg\/kg was used for analgesia in both groups. The RT group was given remimazolam tosilate 0.15\u2009mg\/kg with supplemental doses of 0.05\u2009mg\/kg\u00a0as need, while the propofol group was given propofol 1.5\u2009mg\/kg with supplemental doses of 0.5\u2009mg\/kg. The supplemental doses were determined by the modified observational alertness\/sedation assessment (MOAA\/S) score and the patients\u2019 body movements. Sedative effects, such as the time to loss of consciousness (LOC) (MOAA\/S score\u2009\u2264\u20091), successful sedation in one dose, number of supplemental doses after successful induction, and recovery time, were evaluated. Sedation-related side effects, such as injection pain, haemodynamic events and respiratory depression, were also noted. Postoperative nausea and vomiting (PONV), visual analogue scale (VAS) scores at rest, remedial analgesics, and dizziness or headache were recorded. In addition, patients\u2019 satisfaction and physician\u2019s satisfaction of the procedure were compared between the two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Data from 77 patients were analysed. The success rate of sedation in both groups was 100%. The time to LOC (MOAA\/S score\u2009\u2264\u20091) in the RT group was longer than that in the propofol group (20.7\u2009\u00b1\u20096.1s vs. 13.2\u2009\u00b1\u20095.2s, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). There were fewer patients in the RT group reporting injection pain\u00a0than that in the propofol group (0\/39 vs. 5\/38, <jats:italic>P<\/jats:italic>\u2009=\u20090.025). Haemodynamic events and respiratory depression in the RT group were less frequent than those in the propofol group ((6\/39 vs. 17\/38, <jats:italic>P<\/jats:italic>\u2009=\u20090.005), (2\/39 vs. 9\/38, <jats:italic>P<\/jats:italic>\u2009=\u20090.026), respectively). The number of supplemental doses after successful induction in the RT group was greater than that in the propofol group (4\/9\/11\/13\/1\/1 vs. 8\/4\/18\/6\/2\/0\u00a0requiring 0, 1, 2, 3, 4 or 5 supplemental doses, <jats:italic>P<\/jats:italic>\u2009=\u20090.014). The characteristics of the patients enrolled, postoperative parameters of the patients, and patients\u2019 and physician\u2019s satisfaction of the procedure were comparable in the two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Compared with propofol, RT can be safely and effectively used for gastrointestinal endoscopy sedation in elderly patients, and the incidence of sedation-related adverse reactions, especially haemodynamic events and respiratory depression, is lower. When RT is used, the number of supplemental doses after successful induction may increase slightly.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/chictr.org.cn\">Chictr.org.cn<\/jats:ext-link> ChiCTR2000040498. Retrospectively registered (date of registration: December 1, 2020).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12871-022-01713-6","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T08:25:14Z","timestamp":1654849514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: a prospective, randomized and controlled study"],"prefix":"10.1186","volume":"22","author":[{"given":"Jian","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangjian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinye","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"issue":"10","key":"1713_CR1","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/ajg.2012.246","volume":"107","author":"AC Travis","year":"2012","unstructured":"Travis AC, Pievsky D, Saltzman JR. Endoscopy in the elderly. Am J Gastroenterol. 2012;107(10):1495\u2013501 quiz 4, 502.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"1713_CR2","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.bpg.2009.10.002","volume":"23","author":"K M\u00f6nkem\u00fcller","year":"2009","unstructured":"M\u00f6nkem\u00fcller K, Fry LC, Malfertheiner P, Schuckardt W. Gastrointestinal endoscopy in the elderly: current issues. Best Pract Res Clin Gastroenterol. 2009;23(6):821\u20137.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"1713_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cger.2013.10.010","volume":"30","author":"F Razavi","year":"2014","unstructured":"Razavi F, Gross S, Katz S. Endoscopy in the elderly: risks, benefits, and yield of common endoscopic procedures. Clin Geriatr Med. 2014;30(1):133\u201347.","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"1713_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1197\/j.aem.2006.05.023","volume":"14","author":"A Sacchetti","year":"2007","unstructured":"Sacchetti A, Senula G, Strickland J, Dubin R. Procedural sedation in the community emergency department: initial results of the ProSCED registry. Acad Emerg Med. 2007;14(1):41\u20136.","journal-title":"Acad Emerg Med"},{"issue":"2","key":"1713_CR5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.emc.2004.12.016","volume":"23","author":"MA Miller","year":"2005","unstructured":"Miller MA, Levy P, Patel MM. Procedural sedation and analgesia in the emergency department: what are the risks? Emerg Med Clin North Am. 2005;23(2):551\u201372.","journal-title":"Emerg Med Clin North Am"},{"issue":"12","key":"1713_CR6","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1046\/j.1365-2036.2003.01608.x","volume":"17","author":"LT Heuss","year":"2003","unstructured":"Heuss LT, Schnieper P, Drewe J, Pflimlin E, Beglinger C. Conscious sedation with propofol in elderly patients: a prospective evaluation. Aliment Pharmacol Ther. 2003;17(12):1493\u2013501.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"1713_CR7","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.gie.2015.04.032","volume":"82","author":"F Finkelmeier","year":"2015","unstructured":"Finkelmeier F, Tal A, Ajouaou M, Filmann N, Zeuzem S, Waidmann O, et al. ERCP in elderly patients: increased risk of sedation adverse events but low frequency of post-ERCP pancreatitis. Gastrointest Endosc. 2015;82(6):1051\u20139.","journal-title":"Gastrointest Endosc"},{"issue":"12","key":"1713_CR8","first-page":"929","volume":"13","author":"WK Rogers","year":"2010","unstructured":"Rogers WK, McDowell TS. Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and\/or anesthesia in day-case surgical and non-surgical procedures. IDrugs. 2010;13(12):929\u201337.","journal-title":"IDrugs"},{"issue":"2","key":"1713_CR9","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","volume":"115","author":"LJ Antonik","year":"2012","unstructured":"Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012;115(2):274\u201383.","journal-title":"Anesth Analg"},{"issue":"5","key":"1713_CR10","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1213\/ANE.0b013e3182a705ae","volume":"117","author":"MT Worthington","year":"2013","unstructured":"Worthington MT, Antonik LJ, Goldwater DR, Lees JP, Wilhelm-Ogunbiyi K, Borkett KM, et al. A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy. Anesth Analg. 2013;117(5):1093\u2013100.","journal-title":"Anesth Analg"},{"issue":"4","key":"1713_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1213\/ANE.0000000000000548","volume":"120","author":"KM Borkett","year":"2015","unstructured":"Borkett KM, Riff DS, Schwartz HI, Winkle PJ, Pambianco DJ, Lees JP, et al. A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy. Anesth Analg. 2015;120(4):771\u201380.","journal-title":"Anesth Analg"},{"issue":"5","key":"1713_CR12","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.gie.2015.08.062","volume":"83","author":"DJ Pambianco","year":"2016","unstructured":"Pambianco DJ, Borkett KM, Riff DS, Winkle PJ, Schwartz HI, Melson TI, et al. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2016;83(5):984\u201392.","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"1713_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","volume":"88","author":"DK Rex","year":"2018","unstructured":"Rex DK, Bhandari R, Desta T, DeMicco MP, Schaeffer C, Etzkorn K, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018;88(3):427\u201337 e6.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"1713_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00540-020-02776-w","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020;34(4):491\u2013501.","journal-title":"J Anesth"},{"issue":"4","key":"1713_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00540-020-02788-6","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial. J Anesth. 2020;34(4):543\u201353.","journal-title":"J Anesth"},{"key":"1713_CR16","doi-asserted-by":"publisher","first-page":"109899","DOI":"10.1016\/j.jclinane.2020.109899","volume":"66","author":"J Zhou","year":"2020","unstructured":"Zhou J, Leonowens C, Ivaturi VD, Lohmer LL, Curd L, Ossig J, et al. Population pharmacokinetic\/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects. J Clin Anesth. 2020;66:109899.","journal-title":"J Clin Anesth"},{"key":"1713_CR17","doi-asserted-by":"crossref","unstructured":"Chen W, Chen S, Huang Y. Induction and maintenance of procedural sedation in adults: focus on remimazolam injection. Expert Rev Clin Pharmacol. 2021:1\u201316.","DOI":"10.1080\/17512433.2021.1901575"},{"issue":"1","key":"1713_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.dld.2020.10.039","volume":"53","author":"DK Rex","year":"2021","unstructured":"Rex DK, Bhandari R, Lorch DG, Meyers M, Schippers F, Bernstein D. Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial. Dig Liver Dis. 2021;53(1):94\u2013101.","journal-title":"Dig Liver Dis"},{"issue":"10","key":"1713_CR19","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.23736\/S0375-9393.21.15517-8","volume":"87","author":"G Dai","year":"2021","unstructured":"Dai G, Pei L, Duan F, Liao M, Zhang Y, Zhu M, et al. Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia. Minerva Anestesiol. 2021;87(10):1073\u20139.","journal-title":"Minerva Anestesiol"},{"issue":"4","key":"1713_CR20","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/ALN.0000000000003103","volume":"132","author":"J Schuttler","year":"2020","unstructured":"Schuttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics. Anesthesiology. 2020;132(4):636\u201351.","journal-title":"Anesthesiology"},{"key":"1713_CR21","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3389\/fphar.2018.01316","volume":"9","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Hu P, Huang Y, Nuoer S, Song K, Wang H, et al. Population Pharmacokinetic\/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects. Front Pharmacol. 2018;9:1316.","journal-title":"Front Pharmacol"},{"issue":"8","key":"1713_CR22","first-page":"4594","volume":"12","author":"S Chen","year":"2020","unstructured":"Chen S, Wang J, Xu X, Huang Y, Xue S, Wu A, et al. The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial. Am J Transl Res. 2020;12(8):4594\u2013603.","journal-title":"Am J Transl Res"},{"issue":"2","key":"1713_CR23","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/jgh.15188","volume":"36","author":"SH Chen","year":"2021","unstructured":"Chen SH, Yuan TM, Zhang J, Bai H, Tian M, Pan CX, et al. Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non-inferiority, phase III trial. J Gastroenterol Hepatol. 2021;36(2):474\u201381.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"1713_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4097\/kja.21327","volume":"75","author":"S Ki","year":"2022","unstructured":"Ki S, Cho Y, Choi Y, Lim S, Kim M, Lee J. Effect of chemotherapy on effect-site concentration of propofol for loss of consciousness in patients with colorectal cancer. Korean J Anesthesiol. 2022;75(2):160\u20137.","journal-title":"Korean J Anesthesiol"},{"issue":"1","key":"1713_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12871-020-01049-z","volume":"20","author":"M Chen","year":"2020","unstructured":"Chen M, Lu Y, Liu H, Fu Q, Li J, Wu J, et al. The propofol-sparing effect of intravenous lidocaine in elderly patients undergoing colonoscopy: a randomized, double-blinded, controlled study. BMC Anesthesiol. 2020;20(1):132.","journal-title":"BMC Anesthesiol"},{"issue":"5","key":"1713_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrn2370","volume":"9","author":"TC Jacob","year":"2008","unstructured":"Jacob TC, Moss SJ, Jurd R. GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition. Nat Rev Neurosci. 2008;9(5):331\u201343.","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"1713_CR27","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1111\/bcp.14270","volume":"86","author":"RB Kleiman","year":"2020","unstructured":"Kleiman RB, Darpo B, Thorn M, Stoehr T, Schippers F. Potential strategy for assessing QT\/QTc interval for drugs that produce rapid changes in heart rate: Electrocardiographic assessment of the effects of intravenous remimazolam on cardiac repolarization. Br J Clin Pharmacol. 2020;86(8):1600\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"1713_CR28","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1016\/j.clinthera.2015.10.005","volume":"37","author":"AT Phillips","year":"2015","unstructured":"Phillips AT, Deiner S, Mo Lin H, Andreopoulos E, Silverstein J, Levin MA. Propofol Use in the Elderly Population: Prevalence of Overdose and Association With 30-Day Mortality. Clin Ther. 2015;37(12):2676\u201385.","journal-title":"Clin Ther"},{"issue":"12","key":"1713_CR29","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s40262-018-0672-3","volume":"57","author":"MM Sahinovic","year":"2018","unstructured":"Sahinovic MM, Struys M, Absalom AR. Clinical Pharmacokinetics and Pharmacodynamics of Propofol. Clin Pharmacokinet. 2018;57(12):1539\u201358.","journal-title":"Clin Pharmacokinet"},{"key":"1713_CR30","doi-asserted-by":"publisher","first-page":"d1110","DOI":"10.1136\/bmj.d1110","volume":"342","author":"L Jalota","year":"2011","unstructured":"Jalota L, Kalira V, George E, Shi YY, Hornuss C, Radke O, et al. Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ. 2011;342:d1110.","journal-title":"BMJ"},{"issue":"6","key":"1713_CR31","doi-asserted-by":"publisher","first-page":"617","DOI":"10.4103\/0253-7613.194845","volume":"48","author":"KA Desousa","year":"2016","unstructured":"Desousa KA. Pain on propofol injection: Causes and remedies. Indian journal of pharmacology. 2016;48(6):617\u201323.","journal-title":"Indian journal of pharmacology"},{"issue":"1","key":"1713_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1213\/01.ANE.0000156204.89879.5C","volume":"101","author":"NN Win","year":"2005","unstructured":"Win NN, Fukayama H, Kohase H, Umino M. The different effects of intravenous propofol and midazolam sedation on hemodynamic and heart rate variability. Anesth Analg. 2005;101(1):97\u2013102 table of contents.","journal-title":"Anesth Analg"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01713-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-022-01713-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01713-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T08:26:09Z","timestamp":1654849569000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-022-01713-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1713"],"URL":"https:\/\/doi.org\/10.1186\/s12871-022-01713-6","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]},"assertion":[{"value":"12 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The study has been approved by the Ethics Committee of the Fourth Affiliated Hospital Zhejiang University School of Medicine (approval number: K2020067), and written informed consent was obtained from patients and their families prior to data collection or study intervention. This study adhered to the CONSORT guidelines, and all methods were performed in accordance with the relevant guidelines and regulations (for example- Declarations of Helsinki).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"180"}}